Immunotherapy (Pembrolizumab): clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Immunotherapy (Pembrolizumab)

• A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
  NCT06624644 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma
  NCT06831136 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease
  NCT05229614 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations

Common questions

How many recruiting trials involve Immunotherapy (Pembrolizumab)?

3 recruiting trials across 11 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.